Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Remembering all the things Anavex have said over the years but not followed up on is good sign of not needing blarcamesine.
https://www.courtlistener.com/docket/68337947/blum-v-anavex-life-sciences-corporation/?order_by=desc
Unfortunately the case hasn’t been dismissed because as I have explained that would only happen if no other party complaint or motion for lead plaintiff would be filed before the 13 May deadline.
Instead of shooting blanks or misfiring one could simply check facts from the free source I have provided here more than once.
I would think that too falls under the “longer we wait the sooner we get rich” banner.
Is the list ordered?
Well it’s the legal system of the greatest country on the planet - apparently. What is there not to like?
From my perspective it is immature, but who am I to judge. I simply explain how it works as I know it quite well from prior work.
All the while with retail investors upset that someone is peeing on their fantasy sugar sandwich - and so the nonsense goes on among message board ‘investors’.
It isn’t without cost for law firms to file and then potentially litigate. Those who don’t consider that end up out of business since they only get paid if they are awarded lead plaintiff and the case settles. There is far between the wins, most settlements are relatively small and the winning law firm(s) on average receives 23% of the settlement amount in fees, which in some few instances can be lot and needs to keep the firm afloat til next one. From case to potential payout is years, so not an easy biz do plan cashflow for.
I don’t know how you come to that inference, but for clarity the Kevin Cortina case obviously had no merit.
The current one likely not either, but that has not been established yet.
Missling definitely has a comms lesson to learn and that already have had costs for the company and investors that will likely increase even if the case is eventually dismissed.
You can’t blame the other side for doing their job - that is the system of checks and balances in the U.S.
Whatever pleases your fantasies.
Not Missling’s costs of defending his communications mistakes unless perhaps he can find a cheap Australian government subsidised law firm to defend the case as potentially pivotal dismissal.
The class action case is likely to be an annoying and potentially expensive distraction for Anavex that they could have avoided be acting more professionally.
Hope Missling is steadily learning the commutations and public relations lessons.
We now have two separate complaints filed waiting to be consolidated: https://www.courtlistener.com/docket/68525006/deangelis-v-anavex-life-sciences-corp/
And,
the original Bloom vs. Anavex complaint: https://www.courtlistener.com/docket/68511120/downing-v-anavex-life-sciences-corporation/
As I have said further complaints / motions for lead plaintiff usually comes just as the deadline expires.
This blows out the hope of immediate dismissal per the motion from March.
Hopefully more that than GameOver.
Who knows maybe one day $AVXL will again be a $5 stock.
I hope so, but so far they haven’t been able to handle their own expected catalysts.
Need to see an actual MAA filed, validated and successfully passing clock-stop 1 before I might change my mind about Anavex abilities.
You were still wrong regardless.
As you might understand the whole point of the class action system is to consolidate plaintiffs complaints into one for all similarly situated.
Hopefully you are not surprised by the two complaints being similar.
If the case is weak or is for the court to decide, just like whether Anavex trial results are weak or strong enough for approval is for the appropriate regulatory authorities to decide.
Unfortunately an other class action was filed 8th May, so now the judge can't dismiss the case at least just yet: https://www.courtlistener.com/docket/68511120/downing-v-anavex-life-sciences-corporation/
This case is now referred to Judge Colleen McMahon as possibly related to 1:24-cv-01910-CM. So we now wait longer to find out what the Judge decides next and which if any of the two plaintiffs might be appointed lead plaintiff.
Why only bronze sponsor given how well WGT believe things are going for Anavex - bit cheap skate that.
Thank you to Anovo, @AnavexLifeSci, and DepYmed, the bronze sponsors of this year's ASCEND 2024 Rett Syndrome National Summit! Time is running out to register - reserve your spot today at https://t.co/b5o6vPkyKl. pic.twitter.com/Cpi948SIF3
— International Rett Syndrome Foundation (@Rettsyndrome) May 13, 2024
The fact is that the competition’s placebo effect was more than 3 times worse than the powerful Anavex induced placebo response.
Is a quiet period again! We seem to have had an endless contiguous stream of them.
Oh my! I’m guessing the pumpers aren’t being paid enough given how things are going.
Are you sure anyone cares?
I still want to know where I sign up to get paid for my apparently highly valued posts, but no one has been able to point me in the right direction nor have any handlers approached me on a recommendation.
I guess the demand for bashing $AVXL is just not anywhere near as high as for pumping. This freelancer business sucks, when there no demand for one’s skills and talent - so sad.
Complete BS!
Another quarter and same story - nothing!
The FDA may not have to concern themselves with EMA approving A2-73 first.
$6000, isn’t that amazing for a military grade analyst.
Also I can't recall a single time where he has been mentioned as achieving anything while at Anavex.
Someone asked this question:
“Since you've been following, how did the various allegations consolidate to the lead plaintiff part?”
I provided help to self help. It’s still a case of waiting until 13th May…
I have done that but some here are just on autopilot 💩 reactions. Head under the arm kinda thing - can’t be helped it seems.
Sounds like you would be disappointed if I am right that the case is likely to be dismissed after May 13th.
Just posting the objective facts to correct an incorrect understanding. You will already know my assessment that the case is likely to be dismissed. We just can’t be sure until after May 13th, similar to the fact that we could not be sure if the Anavex clinical trial outcomes would be a slam dunk success until the readouts demonstrated that they were not.
Chill catdaddy and try learn that knowledge and facts are useful concepts for biotech investors and cat lovers.
You might want to correct that as the court has issued a summons addressed to Christopher Missling, which has been duly executed.
I have provided a link to the case, so you are able to verify,
There is however a good chance the case may be dismissed just after May 13, provided there is no motion for lead plaintiff filed by one or more additional law firms.
Generally motions for lead plaintiff are filed just before the deadline.
So now Missling is being sued!
Maybe more modest aspirations, like say $AVXL once again some day becoming a $8 stock, would be a start of something.
I could see that happen much sooner.
Georgejjl seems to have fetish for finding those that go south.
My guess is that your many and deeply insightful posts here played a big part in attracting another actual Dr. to this message board.
And you don't like AI much as I understand from your posts. So what should we think of this post of yours, that is AI manipulation I guess.